GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (FRA:L020) » Definitions » Deferred Tax

Britannia Life Sciences (FRA:L020) Deferred Tax : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Britannia Life Sciences Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Britannia Life Sciences's change in deferred tax for the three months ended in Dec. 2024 was €0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Britannia Life Sciences Deferred Tax Historical Data

The historical data trend for Britannia Life Sciences's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences Deferred Tax Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Deferred Tax
0.03 -0.01 0.02 -0.05

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Britannia Life Sciences Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Britannia Life Sciences Deferred Tax Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Britannia Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (FRA:L020) » Definitions » Deferred Tax
Comparable Companies
XCNQ:GLOW TSXV:CYTO TSXV:QPT TSX:RVX XCNQ:BIOV TSXV:IBO TSX:APS XCNQ:BETR TSXV:IOT TSXV:HEM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
BLAB:Canada
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Website
https://www.britannia.life
Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.

Britannia Life Sciences Headlines

No Headlines